Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): China-United States Collaborative, Population-Based Surveillance and Research Program for Maternal-Child and Family Health, Request for Applications (RFA) DD07-006, 12177-12178 [E7-4744]

Download as PDF Federal Register / Vol. 72, No. 50 / Thursday, March 15, 2007 / Notices burden of the information collections on respondents, including through the use of automated collection techniques or other forms of information technology. At the end of the comment period, the comments and recommendations received will be analyzed to determine the extent to which the collections should be modified prior to submission to OMB for review and approval. Comments submitted in response to this notice also will be summarized or included in the FDIC’s requests to OMB for renewal of these collections. All comments will become a matter of public record. Dated at Washington, DC, this 9th day of March, 2007. Federal Deposit Insurance Corporation. Robert E. Feldman, Executive Secretary. [FR Doc. E7–4678 Filed 3–14–07; 8:45 am] BILLING CODE 6714–01–P FEDERAL ELECTION COMMISSION Sunshine Act Meeting; Notice * * * DATE AND TIME: * * Tuesday, March 20, 2007 at 10 a.m. PLACE: 999 E Street, NW., Washington, DC. STATUS: This meeting will be closed to the public. ITEMS TO BE DISCUSSED: Compliance matters pursuant to 2 U.S.C. 437g. Audits conducted pursuant to 2 U.S.C. 437g, 438(b), and Title 26, U.S.C. Matters concerning participation in civil actions or proceedings or arbitration. Internal personnel rules and procedures or matters affecting a particular employee. PERSON TO CONTACT FOR INFORMATION: Mr. Robert Biersack, Press Officer, Telephone: (202) 694–1220. Mary W. Dove, Secretary of the Commission. [FR Doc. 07–1284 Filed 3–13–07; 12:38 pm] set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)). The notices are available for immediate inspection at the Federal Reserve Bank indicated. The notices also will be available for inspection at the office of the Board of Governors. Interested persons may express their views in writing to the Reserve Bank indicated for that notice or to the offices of the Board of Governors. Comments must be received not later than March 29, 2007. A. Federal Reserve Bank of Atlanta (David Tatum, Vice President) 1000 Peachtree Street, N.E., Atlanta, Georgia 30309: 1. Bill Blanton, Alpharetta, Georgia, as an individual, and a group acting in concert consisting of Bill Blanton, Alpharetta; Gilbert T. Jones, Sr., Jane Jones, Jewels Jones, Brandy Jones, and Barbe Jones, all of Comer; Paula M. Allen, of Dahlonega; Areatha J. Keesey, of Oakwood; Kathy L. Cooper, John Cooper, Tyler Cooper, and Donn H. Cooper, all of Flowery Branch; Robert Allen, of Manchester; Shelley Palmour Anderson, Lanny W. Dunagan, Ann M. Palmour, Wendell A. Turner, Howard Bridges, Rebecca Harrison, James H. McBride, James E. Palmour, Kim Hunter, Victoria Leigh Hunter, Paden Dunagan, C. Danny Dunagan, all of Gainesville; and David C. Harwell, LaVerne Harwell, Douglas F. Harwell, Alice Lipscomb, and Franklin D. Harwell, Jr., all of Winder; all of Georgia, to acquire control of NBOG Bancorporation, Inc., Gainesville, Georgia, and thereby acquire control of The National Bank of Gainesville, Gainesville, Georgia. Board of Governors of the Federal Reserve System, March 12, 2007. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. E7–4793 Filed 3–14–07; 8:45 am] BILLING CODE 6210–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 6715–01–M Centers for Disease Control and Prevention FEDERAL RESERVE SYSTEM rmajette on PROD1PC67 with NOTICES Change in Bank Control Notices; Acquisition of Shares of Bank or Bank Holding Companies The notificants listed below have applied under the Change in Bank Control Act (12 U.S.C. 1817(j)) and § 225.41 of the Board’s Regulation Y (12 CFR 225.41) to acquire a bank or bank holding company. The factors that are considered in acting on the notices are VerDate Aug<31>2005 14:20 Mar 14, 2007 Jkt 211001 Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Cooperative Agreement to the Medical Research Council of South Africa for TB Control and HIV Prevention, Care and Treatment Activities, Program Announcement (PA) Number PS07–006 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease PO 00000 Frm 00014 Fmt 4703 Sfmt 4703 12177 Control and Prevention (CDC) announces a meeting of the aforementioned Special Emphasis Panel. Time and Date: 1 p.m.–2:30 p.m., May 11, 2007 (Closed). Place: Teleconference. Corporate Square, Building 8, Conference Room 6B. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Pub. L. 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of a research application in response to PA PS07–006, ‘‘Cooperative Agreement to the Medical Research Council of South Africa for TB Control and HIV Prevention, Care and Treatment Activities.’’ For Further Information Contact: J. Felix Rogers, Scientific Review Administrator, Centers for Disease Control and Prevention, 1600 Clifton Road, NE., MS E05, Atlanta, GA 30333, telephone 404.639.6101. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: March 8, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–4743 Filed 3–14–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): China-United States Collaborative, Population-Based Surveillance and Research Program for Maternal-Child and Family Health, Request for Applications (RFA) DD07– 006 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned SEP: Time and Date: 1 p.m.–3 p.m., April 26, 2007 (Closed). Place: Teleconference. Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, E:\FR\FM\15MRN1.SGM 15MRN1 12178 Federal Register / Vol. 72, No. 50 / Thursday, March 15, 2007 / Notices Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of scientific merit of grant applications received in response to RFA DD07–006, ‘‘China-United States Collaborative, Population-Based Surveillance and Research Program for Maternal-Child and Family Health.’’ For Further Information Contact: Juliana Cyril, Ph.D., Scientific Review Administrator, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop D72, Atlanta, GA 30333, Telephone 404.639.4639. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: March 8, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–4744 Filed 3–14–07; 8:45 am] Matters to be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to RFA OH 07–002, ‘‘Childhood Agriculture Safety and Health Research.’’ Contact Person For More Information: Stephen Olenchock, Scientific Review Administrator, Office of Extramural Coordination and Special Projects, National Institute for Occupational Safety and Health, CDC, 1095 Willowdale Road, Mailstop P–04, Morgantown, WV 26506, Telephone 304–285–6271. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–4745 Filed 3–14–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Childhood Agriculture Safety and Health Research, Request for Applications (RFA) OH 07–002 Food and Drug Administration [Docket No. 2006N–0472] In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 1 p.m.–3 p.m., April 16, 2007 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Substances Prohibited From Use in Animal Food or Feed; Animal Proteins Prohibited in Ruminant Feed AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. Fax written comments on the collection of information by April 16, 2007. DATES: To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, FAX: 202–395–6974. ADDRESSES: FOR FURTHER INFORMATION CONTACT: Denver Presley, Jr., Office of the Chief Information Officer (HFA–250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301– 827– 1472. In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance. SUPPLEMENTARY INFORMATION: Substances Prohibited from Use in Animal Food or Feed; Animal Proteins Prohibited in Ruminant Feed—21 CFR 589.2000(e)(1)(iv) (OMB Control Number 0910–0339)—Extension This information collection was established because epidemiological evidence gathered in the United Kingdom suggested that bovine spongiform encephalopathy (BSE), a progressively degenerative central nervous system disease, is spread to ruminant animals by feeding protein derived from ruminants infected with BSE. That regulation places general requirements on persons that manufacture, blend, process, and distribute products that contain or may contain protein derived from mammalian tissue, and feeds made from such products. In the Federal Register of December 4, 2006 (71 FR 70409), FDA published a 60-day notice requesting public comment on the information collection provisions. No comments were received. The respondents for this collection of information are manufacturers and or distributors of products that contain or may contain protein derived from mammalian tissues and feeds made from such products. TABLE 1.—ESTIMATED ANNUAL RECORDKEEPING BURDEN1 21 CFR Section No. of Recordkeepers rmajette on PROD1PC67 with NOTICES 589.2000(e)(1)(iv) 1There Annual Frequency per Recordkeeping 400 Total Annual Records 1 Hours per Record 400 14 are no capital costs or operating and maintenance costs associated with this collection of information. VerDate Aug<31>2005 14:20 Mar 14, 2007 Jkt 211001 PO 00000 Frm 00015 Fmt 4703 Sfmt 4703 E:\FR\FM\15MRN1.SGM Total Hours 15MRN1 5,600

Agencies

[Federal Register Volume 72, Number 50 (Thursday, March 15, 2007)]
[Notices]
[Pages 12177-12178]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-4744]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): China-United States Collaborative, Population-
Based Surveillance and Research Program for Maternal-Child and Family 
Health, Request for Applications (RFA) DD07-006

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
SEP:

    Time and Date: 1 p.m.-3 p.m., April 26, 2007 (Closed).
    Place: Teleconference. Centers for Disease Control and 
Prevention, 1600 Clifton Road, Atlanta, GA 30333.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director,

[[Page 12178]]

Management Analysis and Services Office, CDC, pursuant to Public Law 
92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of scientific merit of grant applications 
received in response to RFA DD07-006, ``China-United States 
Collaborative, Population-Based Surveillance and Research Program 
for Maternal-Child and Family Health.''
    For Further Information Contact: Juliana Cyril, Ph.D., 
Scientific Review Administrator, Centers for Disease Control and 
Prevention, 1600 Clifton Road NE, Mailstop D72, Atlanta, GA 30333, 
Telephone 404.639.4639.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: March 8, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. E7-4744 Filed 3-14-07; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.